These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25335968)

  • 1. The implications of regional and national demographic projections for future GMS costs in Ireland through to 2026.
    Conway A; Kenneally M; Woods N; Thummel A; Ryan M
    BMC Health Serv Res; 2014 Oct; 14():477. PubMed ID: 25335968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost containment interventions introduced on the community drugs schemes in Ireland-evaluation of expenditure trends using a national prescription claims database.
    Usher C; Tilson L; Bennett K; Barry M
    Clin Ther; 2012 Mar; 34(3):632-9. PubMed ID: 22381716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ageing, health status and coverage rate effects on community prescription costs in Ireland.
    Kenneally M; Lynch B
    Eur J Health Econ; 2018 Jun; 19(5):687-695. PubMed ID: 28639034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland.
    Tilson L; Bennett K; Barry M
    Eur J Health Econ; 2005 Sep; 6(3):267-73. PubMed ID: 15977036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of prescribing trends and patterns of claims within the Preferred Drugs Initiative in Ireland (2011
    McDowell R; Bennett K; Moriarty F; Clarke S; Barry M; Fahey T
    BMJ Open; 2018 Apr; 8(4):e019315. PubMed ID: 29678966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study.
    Boland F; Galvin R; Reulbach U; Motterlini N; Kelly D; Bennett K; Fahey T
    BMC Pediatr; 2015 Sep; 15():118. PubMed ID: 26357902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public drug expenditure in the Republic of Ireland.
    Barry M; Usher C; Tilson L
    Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):239-45. PubMed ID: 20545588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepine prescribing in children under 15 years of age receiving free medical care on the General Medical Services scheme in Ireland.
    O'Sullivan K; Reulbach U; Boland F; Motterlini N; Kelly D; Bennett K; Fahey T
    BMJ Open; 2015 Jun; 5(6):e007070. PubMed ID: 26059522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National health expenditure projections, 2014-24: spending growth faster than recent trends.
    Keehan SP; Cuckler GA; Sisko AM; Madison AJ; Smith SD; Stone DA; Poisal JA; Wolfe CJ; Lizonitz JM
    Health Aff (Millwood); 2015 Aug; 34(8):1407-17. PubMed ID: 26220668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS; Avorn J; Sarpatwari A
    JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an Online Reimbursement Application System on Prescribing of Lidocaine 5% Medicated Plaster in the Republic of Ireland.
    Smith A; Doran S; Daly M; Kennedy C; Barry M
    Appl Health Econ Health Policy; 2021 Jan; 19(1):133-140. PubMed ID: 32430656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic prescribing trends in a paediatric sub-population in Ireland.
    Keogh C; Motterlini N; Reulbach U; Bennett K; Fahey T
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):945-52. PubMed ID: 22231929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the variation in GMS prescribing expenditure in Ireland.
    ConwayLenihan A; Ahern S; Moore S; Cronin J; Woods N
    Health Econ Rev; 2016 Dec; 6(1):13. PubMed ID: 27025848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National trends in prescription drug expenditures and projections for 2019.
    Schumock GT; Stubbings J; Hoffman JM; Wiest MD; Suda KJ; Rim MH; Tadrous M; Tichy EM; Cuellar S; Clark JS; Matusiak LM; Hunkler RJ; Vermeulen LC
    Am J Health Syst Pharm; 2019 Jul; 76(15):1105-1121. PubMed ID: 31199861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eligibility rates and representativeness of the General Medical Services scheme population in Ireland 2016-2021: A methodological report.
    Mattsson M; Flood M; Wallace E; Boland F; Moriarty F
    HRB Open Res; 2022; 5():67. PubMed ID: 37753170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National health expenditure projections, 2013-23: faster growth expected with expanded coverage and improving economy.
    Sisko AM; Keehan SP; Cuckler GA; Madison AJ; Smith SD; Wolfe CJ; Stone DA; Lizonitz JM; Poisal JA
    Health Aff (Millwood); 2014 Oct; 33(10):1841-50. PubMed ID: 25187525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medication treated type 2 diabetes: a retrospective cross-sectional study using a national pharmacy claims database.
    O'Shea M; Teeling M; Bennett K
    BMC Health Serv Res; 2013 Jan; 13():23. PubMed ID: 23324517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pricing and reimbursement of drugs in Ireland.
    Barry M; Tilson L; Ryan M
    Eur J Health Econ; 2004 Jun; 5(2):190-4. PubMed ID: 15452757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic prescribing in GMS paediatric and young adult population in Ireland 2005-2015: repeated cross-sectional study.
    Conlan K; McGrath J; Teeling M; MacAvin MJ; Bennett K; Gallagher L
    Ir J Psychol Med; 2023 Sep; 40(3):343-352. PubMed ID: 33745473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a price cut reform on the cost and utilization of antidiabetic drugs in Korea: a national health insurance database study.
    Suh HS; Kim JA; Lee IH
    BMC Health Serv Res; 2018 Jun; 18(1):429. PubMed ID: 29879966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.